—Mike Bradley, staff scientist, Array Biopharma
—Heather Brammer, quality assurance manager, ZymoGenetics
—Mike Brandenstein, scientist, Amgen
—Jacqueline Brassard, scientific director, pathology, Allergan
—Heather (Brand) Brett, scientist, Amgen
—Jeff Bridewell, thought leader liaison, Genentech
—Doug Burns, principal, DBC Consulting
—Katie Carrigan, director of human resources, ZymoGenetics
—Jason Carstens, director of process development, CMC Icos
—Shannon Carstens, principal product quality leader, Amgen
—Allen Casey, group leader, high throughput screening/robotics, Infectious Disease Research Institute
—Sommer Castro, research technician, Fred Hutchinson Cancer Research Center
—Tina Catterall, managing partner, Global Interactions
—Shannon Cavallari, training coordinator, PATH
—Shing Chang, R&D director, Drugs for Neglected Diseases Initiative
—David Chantry, senior scientist, Genentech
—Jay Charleston, owner and principal, STNW Consulting, owner of Stereotome NW
—Hao Chen, principal scientist, Calistoga Pharmaceuticals
—Janice Chittenden, director of software quality, NeuroVista
—Michael Cicirelli, scientist, Theraclone Sciences
—Paul Clark, operating partner, Genstar Capital, member of board of directors at Amylin Pharmaceuticals
—Courtney Clark, research associate II, Seattle Genetics
—Darcey Clark, senior scientist, Amgen [Updated: 12:20 pm Pacific, 3/29/10]
—Tony Colasin, consultant, APC Corporate Development & Strategy Consulting
—Anita Colvin, technical scientist, CMC Icos
—Tom Cox, senior associate scientist, Novo Nordisk
—David Crowe, scientist, Mirina
—Dee Czaykowski, life sciences consultant [Added 12/30/09]
—Jeff Dantzler, senior research associate, Novo Nordisk
—Bela Denes, senior director of clinical research and development, Spectrum Pharmaceuticals
—Peter de Vries, associate director of translational sciences, Ikaria
—Mike Deeley, consultant, Somerset Consulting
